Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01510392 · ClinicalTrials.gov registry record
CEI Van Outreach Screening Study
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 118
- Enrollment target
NCT01510392: Completed study, sponsored by Oregon Health and Science University.
NCT01510392 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 118 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01510392 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 118 participants
- Enrollment target
Study Summary
The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is usually accompanied by increased eye pressure. Macular diseases affect sharp, central vision. Keratoconus is a disease that affects the cornea (clear surface covering the colored part of the eye).
Primary Outcome
The primary goal of the trial is to show that OCT technology, specifically the FDA cleared iVue, can be used to effectively screen for glaucoma, macular diseases and keratoconus. The rate of detection of these diseases detected using OCT will be compared to the rate of detection by the physician's exam.
Interventions
- DEVICE OCT imaging, the FDA Cleared iVue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-02-02 |
What the finished NCT01510392 record still lists
NCT01510392 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which OCT imaging, the FDA Cleared iVue is the first listed.
NCT01510392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01510392 about?
NCT01510392 is a clinical study titled "CEI Van Outreach Screening Study". The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is usually accompanied by increased ...
What is the current status of trial NCT01510392?
This trial is currently completed. The enrollment target is 118 participants. The study started on 2012-01. Estimated completion is 2017-02-02.
What interventions are being tested in trial NCT01510392?
The interventions under investigation include: OCT imaging, the FDA Cleared iVue (DEVICE).
Who is sponsoring clinical trial NCT01510392?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia